A prospective, multicenter, observational, post-authorization safety study to evaluate the long term safety profile of LEMTRADA (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (Post Authorization Safety Study (PASS) Protocol).

Project: Research

StatusActive
Effective start/end date31/07/1931/12/24

Keywords

  • Neuroscience
  • Multiple Sclerosis
  • Clinical trial
  • Neuroscience
  • Multiple Sclerosis
  • Clinical trial
  • Neuroscience
  • Multiple Sclerosis
  • Clinical trial